Sarepta Therapeutics Inc New (SRPT)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -76.593 | -5.853 | -24.536 | -41.275 | -23.052 | -13.657 | -22.417 | -16.768 |
| Return on Equity (%) | -101.422 | -9.004 | -39.739 | -77.286 | -70.145 | -49.567 | -107.161 | -86.15 |
| Return on Invested Capital (%) | -98.921 | -22.481 | -26.603 | -52.812 | -39.208 | -27.92 | -32.627 | -16.189 |
| Operating Margin (%) | -4920.31 | -27.718 | -109.257 | -179.399 | -91.301 | -50.638 | -68.243 | -40.061 |
| Net Profit Margin (%) | -4930.179 | -32.79 | -120.225 | -187.766 | -102.597 | -59.665 | -75.4 | -43.108 |
| Book Value Per Share | 6.001 | 11.959 | 14.362 | 10.716 | 9.425 | 10.488 | 4.291 | 8.87 |
| Earnings Per Share | -4.881 | -0.782 | -5.092 | -9.511 | -6.981 | -4.807 | -7.999 | -5.729 |
| Cash Per Share | 2.236 | 9.256 | 5.218 | 11.107 | 18.931 | 24.285 | 10.992 | 4.58 |
| Working Capital Per Share | 5.443 | 17.6 | 17.623 | 16.016 | 26.069 | 24.692 | 22.038 | 20.585 |
| Operating Profit Per Share | 0.097 | 2.272 | 3.755 | 4.313 | 6.006 | 6.942 | 9.017 | 11.684 |
| EBIT Per Share | -4.881 | -0.751 | -5.102 | -9.495 | -6.968 | -4.808 | -7.845 | -5.56 |
| EBITDA Per Share | -4.881 | -0.751 | -5.102 | -9.495 | -6.968 | -4.808 | -7.845 | -5.56 |
| Free Cash Flow Per Share | -4.858 | -0.58 | -4.352 | -8.997 | -6.279 | -4.8 | -8.124 | -5.287 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 54.76M | 64.79M | 71.07M | 75.19M | 79.37M | 87.13M | 87.95M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 87.95M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -199.758 | N/A | N/A | N/A | 11.032 | N/A | N/A |
| Net Profit Margin (%) | N/A | -203.848 | N/A | N/A | N/A | 8.736 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 11.49B |
| Price to Earnings Ratio | -21.43 |
| Price to Sales Ratio | 9.24 |
| Price to Cash Ratio | 26.81 |
| Price to Book Ratio | 13.37 |
| Dividend Yield | - |
| Shares Outstanding | 95.52M |
| Average Volume (1 week) | 752.33k |
| Average Volume (1 Month) | 1.03M |
| 52 Week Change | 26.61% |
| 52 Week High | 173.10 |
| 52 Week Low | 89.92 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
